Estrella Immunopharma nears completion of SPAC listing
The developer of T-cell cancer therapies is based in California, but says it ‘may be subject to risks’ due to its numerous China connections Key Takeaways: Estrella Immunopharma is nearing…
UPTD.US
Fourth Paradigm rides AI wave to IPO, but faces choppy waters
After three failed tries, the leading Chinese AI giant’s listing application was finally accepted by the Hong Kong Stock Exchange Key Takeaways: Fourth Paradigm’s IPO application has been accepted by…
Drink, snack or shares? Vending machine brand Quna seeks IPO cash
The provider of AI-driven marketing solutions for consumer goods retailers is making its third attempt at a share listing Key Takeaways: Qunabox Group has posted rising revenues and adjusted profits…
Dida in new drive on the road to Hong Kong listing
The ride-sharing company made its fourth filing for a Hong Kong IPO at the end of last month, seeking new fuel for its business five years after its last funding…
Hong Kong’s first SPAC pumps up with steel trader ZG Group
Aquila Acquisition said it will merge with the Chinese metal-trading platform, which is facing challenges from weakness in the local real estate market Key Takeaways: ZG Group will raise HK$605…
7836.HK
Malo Medical pitches IPO to help fill China’s dentistry gap
The provider of high-end dental services has attracted well-known investors but has yet to break even after 11 years in business, due to high sales costs Key Takeaways: Malo Medical…
HeyTea brings its bubbly brew to Europe. But are its prospects deflating?
Chaotic opening in London’s Chinatown may create the wrong kind of buzz as China’s leading bubble-tea chain tries to expand beyond Asia Key Takeaways: HeyTea’s opening of a London store,…
